tiprankstipranks
Advertisement
Advertisement

ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up

ImmunityBio, Keysight, Rubrik, AFLAC, Moody’s Insider Shake-Up

Insiders have been trading these 5 stocks: ((IBRX)), ((KEYS)), ((RBRK)), ((AFL)) and ((MCO)). Here is a breakdown of their recent trades and their value.

Claim 30% Off TipRanks

CEO Shiong Patrick Soon just made a bold bet on ImmunityBio, scooping up 4,606,596 shares in a single move. The purchase is worth a striking $24,967,750, signaling strong insider confidence that will catch the eye of investors watching biotech momentum.

At Keysight Technologies, Director Richard Hamada moved in the opposite direction, cashing out a slice of his stake. He sold 870 shares for a total of $239,928, a relatively small but notable insider sale that may spark questions about near-term valuation.

Cybersecurity and cloud data name Rubrik, Inc. Class A is seeing insider accumulation as Director Mark Mclaughlin steps in as a buyer. His purchase of 10,638 shares, valued at $502,219, suggests growing conviction in the company’s long-term growth story.

AFLAC is seeing major activity from significant shareholder Japan Post Holdings Co., Ltd., which has been steadily trimming its position. It sold 19,600 shares for $2,153,035, 14,900 shares for $1,608,877, 14,500 shares for $1,555,820, and 14,700 shares for $1,590,988, marking a sizable multi-tranche exit.

At Moody’s, President & CEO Robert Fauber has joined the ranks of recent insiders taking profits. He sold 300 shares of Moody’s stock for $131,331, a modest transaction that still offers a window into executive portfolio moves at the credit ratings powerhouse.

Disclaimer & DisclosureReport an Issue

1